论文部分内容阅读
目的观察雾化吸入普米克令舒和万托林治疗小儿喘息性疾病急性发作的临床疗效。方法2003年l2月至2006年l2月120例以喘息为主要表现的婴幼儿随机分为2组,对照组在常规治疗的基础上,静脉滴注氨茶碱平喘;治疗组常规治疗同对照组,利用空气压缩泵雾化吸入普米克令舒悬液及万托林平喘。观察所有患儿症状、体征在72h之内的改善情况以及消失时间。结果治疗组在治疗72h时的显效率高于对照组。结论联合雾化吸入普米克令舒和万托林能够快速缓解患儿的症状、缩短住院时间,是一种方便、有效、安全的用药方案。
Objective To observe the clinical efficacy of inhalation of pulmicort respules and wantroplin in the treatment of acute attack of asthmatic children. Methods From January 2003 to December 2006, 120 infants and young children with asthma as the main manifestation were randomly divided into two groups. The control group received intravenous aminophylline for asthma on the basis of routine treatment. The conventional treatment in the treatment group was the same as the control Group, the use of air compression pump inhalation Pulmicort resveratrol and Wantropin asthma. Observation of all children with symptoms and signs of improvement within 72h and the disappearance of time. Results The effective rate of treatment group at 72h was higher than that of control group. Conclusions The combined inhalation of pulmicort and vanvlint can quickly relieve the symptoms of children and shorten the hospital stay, which is a convenient, effective and safe medication regimen.